NO20023041L - Fremgangsmåte for fremstilling av pyrazolopyridazinderivater - Google Patents

Fremgangsmåte for fremstilling av pyrazolopyridazinderivater

Info

Publication number
NO20023041L
NO20023041L NO20023041A NO20023041A NO20023041L NO 20023041 L NO20023041 L NO 20023041L NO 20023041 A NO20023041 A NO 20023041A NO 20023041 A NO20023041 A NO 20023041A NO 20023041 L NO20023041 L NO 20023041L
Authority
NO
Norway
Prior art keywords
alkyl
nrr
fluorine atoms
substituted
preparation
Prior art date
Application number
NO20023041A
Other languages
English (en)
Other versions
NO20023041D0 (no
NO323412B1 (no
Inventor
Neil Mathews
Richard Anthony Ward
Andrew Jonathan Whitehead
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO20023041D0 publication Critical patent/NO20023041D0/no
Publication of NO20023041L publication Critical patent/NO20023041L/no
Publication of NO323412B1 publication Critical patent/NO323412B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • C07C317/24Sulfones; Sulfoxides having sulfone or sulfoxide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/08Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

Oppfinnelsen tilveiebringer en fremgangsmåte for fremstilling av en forbindelse av formel (1). og farmasøytisk akseptable derivater derav i hvilke R°er halogen, d-alkyl, C,-alkoksy, Calkoksy substituert med et eller flere fluoratomer eller 0(CH)„NRR; R' og R 2 er uavhengig valgt blant H, Calkyl, Q-alkyl substituert med et eller flere fluoratomer, Calkoksy, ChydroksyaIkyl, SCi-alkyl, C(0)H, C(0)CaIkyl, C|-alkyIsulfonyI, Cr6alkoksy substituert med et eller flere fluoratomer, 0(CH)„.C0-. Cr-alkyl, 0(CH)„SC-alkyI, (CH)NRR, (CH)SC-alkyl eller C(0)NRR; med. det forbehold at når R° er på 4-posisjon og er halogen, er minst en av R, og R 2. Calkylsulfonyl, Calkoksy substituert med et eller flere fluoratomer,. 0(CH)n02Cr6aIkyl, 0(CH)SCaIkyI, (CH)NRReller (CH)SC,-alkyl,. C(0)NRR; Rer C ,-alkyl eller NH; R 4 og Rer uavhengig valgt blant H eller C,-aIkyl eller danner sammen med nitrogenatornet til hvilket de er bundet en 4-8 leddet mettet ring og n er 1-4; hvilken omfatter oksidering av en tilsvarende forbindelse av formel (fl) eller en isomer derav.
NO20023041A 1999-12-22 2002-06-21 Fremgangsmate for fremstilling av pyrazolopyridazinderivater og mellomprodukter. NO323412B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9930358.8A GB9930358D0 (en) 1999-12-22 1999-12-22 Process for the preparation of chemical compounds
PCT/EP2000/013001 WO2001046194A2 (en) 1999-12-22 2000-12-20 Process for the preparation of pyrazolo[1,5-b]pyridazine derivatives

Publications (3)

Publication Number Publication Date
NO20023041D0 NO20023041D0 (no) 2002-06-21
NO20023041L true NO20023041L (no) 2002-08-16
NO323412B1 NO323412B1 (no) 2007-04-30

Family

ID=10866856

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20023041A NO323412B1 (no) 1999-12-22 2002-06-21 Fremgangsmate for fremstilling av pyrazolopyridazinderivater og mellomprodukter.

Country Status (22)

Country Link
US (1) US6803463B2 (no)
EP (1) EP1242424B1 (no)
JP (1) JP2003518121A (no)
KR (1) KR20020062362A (no)
CN (1) CN1197864C (no)
AT (1) ATE299506T1 (no)
AU (1) AU776777B2 (no)
BR (1) BR0016549A (no)
CA (1) CA2395569A1 (no)
CZ (1) CZ20022178A3 (no)
DE (1) DE60021286T2 (no)
ES (1) ES2243343T3 (no)
GB (1) GB9930358D0 (no)
HK (1) HK1047586B (no)
HU (1) HUP0203407A3 (no)
IL (1) IL150274A0 (no)
MX (1) MXPA02006132A (no)
NO (1) NO323412B1 (no)
NZ (1) NZ519691A (no)
PL (1) PL356141A1 (no)
WO (1) WO2001046194A2 (no)
ZA (1) ZA200204911B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0021494D0 (en) * 2000-09-01 2000-10-18 Glaxo Group Ltd Chemical comkpounds
GB0112810D0 (en) * 2001-05-25 2001-07-18 Glaxo Group Ltd Pyrimidine derivatives
GB0112802D0 (en) * 2001-05-25 2001-07-18 Glaxo Group Ltd Pyrimidine derivatives
ATE325115T1 (de) 2002-08-19 2006-06-15 Glaxo Group Ltd Pyrimidinderivate als selektive cox-2-inhibitoren
GB0221443D0 (en) 2002-09-16 2002-10-23 Glaxo Group Ltd Pyridine derivates
GB0227443D0 (en) * 2002-11-25 2002-12-31 Glaxo Group Ltd Pyrimidine derivatives
GB0229808D0 (en) 2002-12-20 2003-01-29 Glaxo Group Ltd Novel compositions
US7145762B2 (en) * 2003-02-11 2006-12-05 Taser International, Inc. Systems and methods for immobilizing using plural energy stores
GB0319037D0 (en) * 2003-08-13 2003-09-17 Glaxo Group Ltd 7-Azaindole Derivatives
DE102006040754B3 (de) * 2006-08-31 2008-03-27 Knorr-Bremse Systeme für Nutzfahrzeuge GmbH Scheibenbremse, insbesondere für ein Nutzfahrzeug

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58134094A (ja) * 1982-02-02 1983-08-10 Mitsubishi Paper Mills Ltd 3―ホルミル―ピラゾロ〔1,5―b〕ピリダジン類
US5002941A (en) 1985-12-12 1991-03-26 Smithkline Beecham Corporation Pyrrolo(1,2-a)imidazole and imidazo(1,2-a)pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors
US4925849A (en) 1987-06-15 1990-05-15 Fujisawa Pharmaceutical Company, Ltd. Pharmaceutically useful pyrazolopyridines
US5155114A (en) 1989-01-23 1992-10-13 Fujisawa Pharmaceutical Company, Ltd. Method of treatment using pyrazolopyridine compound
GB8901423D0 (en) 1989-01-23 1989-03-15 Fujisawa Pharmaceutical Co Pyrazolopyridine compound and processes for preparation thereof
JPH05503919A (ja) 1989-06-13 1993-06-24 スミスクライン・ビーチャム・コーポレイション 単球および/またはマクロファージによるインターロイキン―1または腫瘍壊死因子生成の抑制
AU622330B2 (en) 1989-06-23 1992-04-02 Takeda Chemical Industries Ltd. Condensed heterocyclic compounds having a nitrogen atom in the bridgehead for use as fungicides
AU8205991A (en) 1990-06-12 1992-01-07 Smithkline Beecham Corporation Inhibition of 5-lipoxygenase and cyclooxygenase pathway mediated diseases
GB9015764D0 (en) 1990-07-18 1990-09-05 Fujisawa Pharmaceutical Co Pyrazolopyridine compound and processes for preparation thereof
US5300478A (en) 1993-01-28 1994-04-05 Zeneca Limited Substituted fused pyrazolo compounds
US5474995A (en) 1993-06-24 1995-12-12 Merck Frosst Canada, Inc. Phenyl heterocycles as cox-2 inhibitors
US5521213A (en) 1994-08-29 1996-05-28 Merck Frosst Canada, Inc. Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2
US5552422A (en) 1995-01-11 1996-09-03 Merck Frosst Canada, Inc. Aryl substituted 5,5 fused aromatic nitrogen compounds as anti-inflammatory agents
CN1186492A (zh) * 1995-04-04 1998-07-01 葛兰素集团有限公司 咪唑并[1,2-α]吡啶衍生物
ES2247604T3 (es) 1995-06-12 2006-03-01 G.D. SEARLE & CO. Composiciones que comprenden un inhibidor de ciclooxigenasa-2 y un inhibidor de 5-lipoxigenasa.
EP0833664A1 (en) 1995-06-12 1998-04-08 G.D. SEARLE & CO. Combination of a cyclooxygenase-2 inhibitor and a leukotriene b 4? receptor antagonist for the treatment of inflammations
US5700816A (en) 1995-06-12 1997-12-23 Isakson; Peter C. Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a leukotriene A4 hydrolase inhibitor
DK1032575T3 (da) * 1997-09-05 2003-10-20 Glaxo Group Ltd 2,3-diaryl-pyrazol(1,5-b)pyridazinderivater, deres fremstilling og anvendelse som cyclooxygenase 2 (COX-2) inhibitor
ATE261444T1 (de) * 1999-02-27 2004-03-15 Glaxo Group Ltd Pyrazolopyridine
GB9919778D0 (en) 1999-08-21 1999-10-27 Zeneca Ltd Chemical compounds

Also Published As

Publication number Publication date
CA2395569A1 (en) 2001-06-28
AU2675101A (en) 2001-07-03
HUP0203407A3 (en) 2004-12-28
HK1047586B (en) 2005-12-16
IL150274A0 (en) 2002-12-01
CN1413215A (zh) 2003-04-23
ATE299506T1 (de) 2005-07-15
HUP0203407A2 (hu) 2003-01-28
PL356141A1 (en) 2004-06-14
KR20020062362A (ko) 2002-07-25
EP1242424A2 (en) 2002-09-25
MXPA02006132A (es) 2002-12-05
GB9930358D0 (en) 2000-02-09
WO2001046194A2 (en) 2001-06-28
NZ519691A (en) 2004-06-25
JP2003518121A (ja) 2003-06-03
WO2001046194A3 (en) 2002-05-30
DE60021286T2 (de) 2005-12-29
ES2243343T3 (es) 2005-12-01
EP1242424B1 (en) 2005-07-13
CN1197864C (zh) 2005-04-20
HK1047586A1 (en) 2003-02-28
BR0016549A (pt) 2002-09-17
CZ20022178A3 (cs) 2003-02-12
NO20023041D0 (no) 2002-06-21
ZA200204911B (en) 2004-02-13
NO323412B1 (no) 2007-04-30
DE60021286D1 (de) 2005-08-18
US20030078267A1 (en) 2003-04-24
US6803463B2 (en) 2004-10-12
AU776777B2 (en) 2004-09-23

Similar Documents

Publication Publication Date Title
EA200000188A1 (ru) Производные 2,3-диарил-пиразоло[1,5-b]-пиридазинов, их получение и их применение в качестве ингибиторов циклооксигеназы-2 (цог-2)
MXPA02012033A (es) Derivados de 2-aminocarbonil-9h-purina.
MY109737A (en) Treatment and compounds.
IL158459A0 (en) Quinoline derivatives and quinazoline derivatives having azolyl group
AU4306796A (en) Novel 3,5-dioxo-(2h,4h)-1,2,4-triazine derivatives, their preparation and use as drugs
HUP0002112A2 (hu) Helyettesített 3-ciano-kinolinok, előállításuk és alkalmazásuk, valamint e vegyületeket tartalmazó gyógyászati készítmények
DE69529418D1 (de) Cyclopropachromencarbonsäure derivate
NO20052074L (no) Substituerte benzoksazinoner og anvendelser derav.
NO20023041L (no) Fremgangsmåte for fremstilling av pyrazolopyridazinderivater
PL432858A1 (pl) Związki stanowiące C20-modyfikowane pochodne salinomycyny, sposób ich otrzymywania, kompozycja je zawierająca, zastosowanie tych związków oraz sposób otrzymywania produktu pośredniego
TW360652B (en) Acryloyl substituted disstamycin derivatives, process for preparing them, and pharmaceutical composition comprising them
MY118004A (en) Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
AU3415599A (en) Benzoheterocyclic distamycin derivatives, process for preparing them, and their use as antitumor agents
MY138826A (en) 2,7-substituted indoles
NO972887L (no) Piperidineddiksyrederivater anvendelige som fibrinogen-antagonistmiddel
IL133414A0 (en) Benzo (5, 6) cycloheptapyridine cyclic ureas and lactams useful as farnesyl protein transferase inhibitors
MXPA04002838A (es) Derivados de alquilaminopiridazinona sustituidos, procedimiento para la preparacion de los mismos y composiciones farmaceuticas que los contienen.
ES2102295A1 (es) Nuevos compuestos derivados de la n-benzoilmetil-piperidina.
DK0885004T3 (da) Anvendelse af 4-phenyl-3,6-dihydro-2H-pyridyl-derivater som NMDA-receptor-undertypeblokkere
DE69725167D1 (de) N-benzolsulfonyl-l-prolin derivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung
AU2001259242A1 (en) Process for the preparation of chemical compounds
ATE275133T1 (de) 1,2-dihydro-2-oxochinolin-derivate
NO885224L (no) Fremgangsmaate for fremstilling av 1,4-disubstituerte-piperidinylderivater.
NO973341L (no) Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for vasodilatorisk behandling eller profylakse
HUP0402149A2 (hu) Vízoldható fenil-piridazin-származékok, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények